Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), TransMedics Group (TMDX) and Incyte (INCY)
Harmony Biosciences Holdings Sell Rating: Concerns Over Product Differentiation, Patent Litigation, and R&D Pipeline
Harmony Biosciences Analyst Ratings
Needham Maintains Buy on Harmony Biosciences, Raises Price Target to $52
Analysts' Opinions Are Mixed on These Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Decibel Cannabis Company (OtherDBCCF) and Avid Bioservices (CDMO)
Harmony Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY), Moderna (MRNA) and Ionis Pharmaceuticals (IONS)
Piper Sandler Remains a Buy on Harmony Biosciences Holdings (HRMY)
Harmony Biosciences Analyst Ratings
Harmony Biosciences Holdings (HRMY) Gets a Sell From Goldman Sachs
Analysts Are Bullish on Top Healthcare Stocks: Harmony Biosciences Holdings (HRMY), Recursion Pharmaceuticals (RXRX)
Harmony Biosciences Analyst Ratings
Harmony Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Astria Therapeutics (ATXS)
Harmony Biosciences Analyst Ratings
Harmony Biosciences Analyst Ratings
Needham Maintains Buy on Harmony Biosciences, Lowers Price Target to $50
Harmony Biosciences Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Harmony Biosciences Holdings (HRMY) and Tandem Diabetes Care (TNDM)
Harmony Biosciences Analyst Ratings
No Data